Cargando…
Signal pathways and precision therapy of small-cell lung cancer
Small-cell lung cancer (SCLC) encounters up 15% of all lung cancers, and is characterized by a high rate of proliferation, a tendency for early metastasis and generally poor prognosis. Most of the patients present with distant metastatic disease at the time of clinical diagnosis, and only one-third...
Autores principales: | Yuan, Min, Zhao, Yu, Arkenau, Hendrik-Tobias, Lao, Tongnei, Chu, Li, Xu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200817/ https://www.ncbi.nlm.nih.gov/pubmed/35705538 http://dx.doi.org/10.1038/s41392-022-01013-y |
Ejemplares similares
-
Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence
por: Voskoboynik, Mark, et al.
Publicado: (2014) -
Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
por: Shih, Kent, et al.
Publicado: (2014) -
Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice
por: Lemech, Charlotte, et al.
Publicado: (2011) -
Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities
por: Lemech, Charlotte, et al.
Publicado: (2012) -
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities
por: Fontana, Elisa, et al.
Publicado: (2020)